Metabotropic glutamate receptor antagonists, like GABA(B) antagonists, potentiate dorsal root-evoked excitatory synaptic transmission at neonatal rat spinal motoneurons in vitro

被引:21
作者
Cao, CQ [1 ]
Tse, HW [1 ]
Jane, DE [1 ]
Evans, RH [1 ]
Headley, PM [1 ]
机构
[1] UNIV BRISTOL,SCH MED SCI,DEPT PHYSIOL,BRISTOL BS8 1TD,AVON,ENGLAND
基金
英国惠康基金;
关键词
metabotropic glutamate receptors; motoneurons; spinal cord; whole-cell voltage-clamp recording; MAP4; MCCG;
D O I
10.1016/S0306-4522(96)00579-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recordings of whole-cell synaptic current responses elicited by electrical stimulation of dorsal roots were made from motoneurons, identified by antidromic invasion, in isolated spinal cord preparations from five- to eight-day-old Wistar rats. Supramaximal electrical stimulation of the dorsal root evoked complex excitatory postsynaptic currents with mean latencies (+/- S.E.M.) of 6.1 +/- 0.26 ms, peak amplitude of - 650 +/- 47 pA and duration of 4.30 +/- 0.46 s (n=34). All phases of excitatory postsynaptic currents were potentiated to approximately 20% above control levels in the presence of the metabotropic glutamate receptor antagonists S-2-amino-2-methyl-4-phosphonobutanoate (MAP4; 200 mu M; n=15) and 2S,1'S,2'S-2-methyl-2-(carboxycyclopropyl)glycine (MCCG; 200 mu M; n=9). A similar level of potentiation was produced by the GABA(B) recept or antagonist 3-N[1-(S)-(3,4-dichlorophenyl)ethyl]amino-2-(S)-hydroxypropyl-P-benzyl-phosphinic acid (CGP55845; 200 nM; n=5). MAP4 (200 mu M) produced a six-fold rightward shift in the concentration-effect plot for the depressant action of the metabotropic glutamate receptor agonist S-2-amino-4-phosphonobutanoate (L-AP4), whereas CGP55845 produced no significant change in the potency of L-AP4. MAP4 did not antagonize the depressant actions of baclofen (n=8), 1S,3S-1-aminocyclopentane-1,3-dicarboxylate (n=4) or 2-S,1'S,2'S-2-(carboxycyclopropyl)glycine (n=4). The metabotropic glutamate receptor antagonists produced no change in the holding current of any of the neurons, indicating that they had no significant postsynaptic excitatory actions. These results are the first to indicate a possible physiological role for metabotropic glutamate receptors in the spinal cord. Like GABA(B) receptors, they control glutamatergic synaptic transmission in the segmental spinal pathway to motoneurons. This is likely to be a presynaptic control mechanism. (C) 1997 IBRO.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 23 条
[1]   THE PRIMARY AFFERENT DEPOLARIZING ACTION OF KAINATE IN THE RAT [J].
AGRAWAL, SG ;
EVANS, RH .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (02) :345-355
[2]   THE DEPRESSANT ACTION OF BACLOFEN ON THE ISOLATED SPINAL-CORD OF THE NEONATAL RAT [J].
AULT, B ;
EVANS, RH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 71 (04) :357-364
[3]   PRESYNAPTIC AND POSTSYNAPTIC GLUTAMATE RECEPTORS AT A GIANT EXCITATORY SYNAPSE IN RAT AUDITORY BRAIN-STEM SLICES [J].
BARNESDAVIES, M ;
FORSYTHE, ID .
JOURNAL OF PHYSIOLOGY-LONDON, 1995, 488 (02) :387-406
[4]   ANTAGONISM OF BACLOFEN-INDUCED DEPRESSION OF WHOLE-CELL SYNAPTIC CURRENTS IN SPINAL DORSAL HORN NEURONS BY THE POTENT GABA(B) ANTAGONIST CGP55845 [J].
BLAKE, JF ;
CAO, CQ ;
HEADLEY, PM ;
COLLINGRIDGE, GL ;
BRUGGER, F ;
EVANS, RH .
NEUROPHARMACOLOGY, 1993, 32 (12) :1437-1440
[5]  
BLAKE JF, 1993, BRIT J PHARMACOL, V111, pP94
[6]   WHOLE CELL RECORDING FROM NEURONS IN SLICES OF REPTILIAN AND MAMMALIAN CEREBRAL-CORTEX [J].
BLANTON, MG ;
LOTURCO, JJ ;
KRIEGSTEIN, AR .
JOURNAL OF NEUROSCIENCE METHODS, 1989, 30 (03) :203-210
[7]   Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices [J].
Bushell, TJ ;
Jane, DE ;
Tse, HW ;
Watkins, JC ;
Garthwaite, J ;
Collingridge, GL .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (07) :1457-1462
[8]   A COMPARISON OF THE EFFECTS OF SELECTIVE METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS ON SYNAPTICALLY EVOKED WHOLE-CELL CURRENTS OF RAT SPINAL VENTRAL HORN NEURONS IN-VITRO [J].
CAO, CQ ;
EVANS, RH ;
HEADLEY, PM ;
UDVARHELYI, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (08) :1469-1474
[9]  
CAO CQ, 1995, BRIT J PHARMACOL, V114, pP14
[10]  
CAO CQ, 1995, J PHYSIOL-LONDON, V483P, pP159